Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for pain after tibial plateau surgery
NCT04639011Phase 4Withdrawn
- Sponsor
- Boston Medical Center
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of duloxetine in postoperative pain, sponsored by Boston Medical Center. Primary endpoint: Pain levels in the first 16 hours after surgery. Planned start Oct 2022; status: withdrawn.
02
Drugs
duloxetine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04639011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04639011.